Senco Gold glitters, hits new high after ICICI Pru buys stake

Senco Gold glitters, hits new high after ICICI Pru buys stake


Shares of Senco Gold were up 3.55 per cent at Rs 1,380 per share on the BSE.

Senco Gold shares climbed 5.5 per cent intraday to scale an all-time high of Rs 1,406 on the BSE on Tuesday. The stock gained a day after Oman India Joint Investment Fund II sold 5,89,917 shares via a block deal at Rs 1,280.16 per share. 


Conversely, ICICI Prudential Life Insurance Company bought 4,90,705 shares in the company at Rs 1,280 per share through another block deal.


As of June 2024, Oman India Joint Investment Fund II held a 2.03 per cent stake in the company.


At around 11:37 AM, shares of Senco Gold were up 3.55 per cent at Rs 1,380 per share on the BSE. In comparison, the BSE Sensex traded 0.09 per cent lower at 84,850 around the same time.

 


Emkay Global had reiterated its ‘Buy’ rating on Senco Gold in a report dated September 17, 2024.


The brokerage has increased the company’s multiple by 15 per cent to 36x earnings per share (EPS) on the back of improved medium-term growth profile with a big 900 basis points (bps) duty cut (on gold) and outperformance against other retail formats.


Senco Gold Q1FY25 results


In terms of financials, Senco Gold reported a net profit of Rs 51.27 crore for the first quarter of the current fiscal (April-June 2024), marking an 85.4 per cent year-on-year (Y-o-Y) increase from the year-ago period.


The Kolkata-based gold and diamond jewellery chain saw a 7.5 per cent YoY growth in consolidated revenue, at Rs 1,403.89 crore for the quarter ended June 30.


The company’s earnings before interest, tax, depreciation, and amortisation (Ebitda) surged by 61.8 per cent to Rs 108.74 crore in Q1FY25.


The jewellery retailer also expanded its retail footprint by opening six new showrooms, bringing its total count to 165, which included a store in Dubai. Retail sales of the company grew 9.6 per cent year-on-year, while same-store sales growth stood at 4 per cent during the quarter.


In the past one year, shares of Senco Gold have gained 166.64 per cent, compared to the BSE Sensex’s rise of 28.7 per cent during the same period. 

First Published: Sep 24 2024 | 1:01 PM IST



Source link

JPMorgan bullish on India, Japan; to allocate resources in Southeast Asia

JPMorgan bullish on India, Japan; to allocate resources in Southeast Asia


China Plus One is a strategy that businesses are following to diversify investment and supply chains from China into other countries | File image


JPMorgan, the largest bank in the US, is bullish on India and Japan within Asia but is also keen to allocate resources towards Southeast Asia, which is benefiting from the “China Plus One” strategy, a top official at the bank said.

 


“India is still firmly in the top three, possibly top two in Asia, together with Japan. Growth in India is actually very broad-based,” Sjoerd Leenart, JPMorgan’s Asia Pacific CEO, said in an interview on Monday.

 


“We are investing on all fronts in India. We’re adding bankers, we’re putting more capital into the business and we’re building capabilities such as technology investments to service new segments of the market,” he added.

 

 


JPMorgan expects its commercial banking business, which is focused on mid-sized companies, to grow as much as 30 per cent in India over the next few years, Leenart said.

 


India would need to further build its manufacturing ecosystem and ensure scalability to gain from the “China Plus One” strategy which has currently largely benefited the Southeast Asian countries, he added.

 


China Plus One is a strategy that businesses are following to diversify investment and supply chains from China into other countries.

 


“In India this next leg will to an extent be about becoming a manufacturing hub, creating blue collar jobs, and that’s an opportunity, but it’s almost a necessity for India,” Leenart said.

 


“So if that strategy doesn’t work, then India may not do as well as people expect. That’s probably the hardest to execute,” he said, adding he still expected India could succeed.

 


On Japan, Leenart said with interest rates now positive, clients have become interested again and from a corporate activity and rates view, the country is full of opportunity.

 


JPMorgan’s business in China has been growing significantly and Leenart said despite concerns about slow economic growth there, the country cannot be ignored.

 


“We’re actually very excited about what we have in China. We have all the capabilities, and we’re looking to maximize the opportunity that we have with domestic clients and international clients. It’s been growing actually nicely.” JPMorgan is looking to invest in Southeast Asia, where the size of the combined economies is around $3 trillion, making it almost as big as India, Leenart said.

 


“Obviously it is a little bit more difficult to navigate because it’s fragmented across five or six countries, but that’s a place where we are keen to invest.”


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Sep 24 2024 | 12:04 PM IST



Source link

Arkade Developers shares make strong debut, list at 37% premium on bourses: Arkade Developers IPO

Arkade Developers shares make strong debut, list at 37% premium on bourses: Arkade Developers IPO



Shares of Arkade Developers made a good share market debut on Tuesday, however was lower than Street’s expectations. Arkade Developers’ shares listed at Rs 175.9, reflecting a premium of 37.42 per cent against the IPO issue price of Rs 128.

Similarly, on the NSE, shares of Arkade Developers listed at a premium of 36.71 per cent at Rs 175, against the IPO issue price, on Tuesday. The Street expected 49.22 per cent premium at Rs 191 per share. 

Few minutes after the listing the stock edged higher. Last seen, on BSE, the stock gained 3.92 per cent or Rs 6.9 at Rs 182.8 per share. On NSE, the shares were up 3.85 per cent or Rs 6.73 at Rs 181.73 per share. 

 


Accordingly, with the listing debut of Arkade Developers, investors who were allotted the company’s shares made a gain of Rs 47.9 apiece, or over 37.42 per cent per share.


Ahead of the listing, Arkade Developers’ shares traded at a premium of Rs 63 apiece, or 49.22 percent, indicating a favourable market debut.


The public issue of Arkade Developers comprised an entirely fresh issue of 32,031,250 shares, available at a price band of Rs 121-128, and a lot size of 110 shares. The bidding for the Arkade Developers IPO started on Monday, September 16, 2024, and concluded on Thursday, September 19, 2024, receiving a whopping 106.83 times oversubscription, as per the data available on the NSE. This was led by Qualified Institutional Buyers (QIBs) and Non-Institutional Investors who bid for 163.16 and 163.02 times respectively. Meanwhile, the quota reserved for Retail Individual Investors (RIIs) and Employees got subscribed 51.39 times and 50.49 times respectively, as per the NSE data. The allotment of Arkade Developers IPO was finalised on Friday, September 20, 2024.


Arkade Developers said that it intends to use the net proceeds from the IPO for the development of the company’s ongoing as well as upcoming projects, funding the acquisition of future real estate projects, and general corporate purposes.


Arkade Developers is a leading real estate developer with a legacy spanning over three decades, renowned for crafting luxurious residential and commercial properties with a significant presence in Mumbai. The company operates its business in two segments which include the development/construction of residential buildings on land acquired by the company (new projects) and the redevelopment of existing buildings (redevelopment projects).

First Published: Sep 24 2024 | 10:10 AM IST



Source link

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions


Astrazeneca Pharma India said that it has received permission from Central Drugs Standard Control Organisation (CDSCO) to import for sale and distribution of Durvalumab solutions (IMFINZI) in India.

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI as monotherapy after surgery, is indicated for the treatment of patients with resectable (tumours 4 cm and/or node positive) NSCLC and no known epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements.

The receipt of this permission paves way for the launch of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion (Imfinzi) in India.

 

AstraZeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company.

The pharmaceutical firm reported net loss of Rs 11.79 crore in Q1 FY25 as compared to net profit of Rs 53.86 crore recorded in Q1 FY24. Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30 June 2024

The counter declined 1.69% to ends at Rs 6,746.45 on Monday, 23 September 2024.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Sep 24 2024 | 8:54 AM IST



Source link

Stock Market LIVE Updates: GIFT Nifty signals higher open for Sensex, Nifty; China rolls out support

Stock Market LIVE Updates: GIFT Nifty signals higher open for Sensex, Nifty; China rolls out support


Stock Market LIVE Updates, Tuesday, September 24, 2024: Indian equity benchmark indices were set for a positive open on Tuesday, after US benchmark indices S&P 500 and the Dow set fresh record closing highs on Wall Street overnight.




At 7:28 AM, GIFT Nifty futures were trading at 25,982, around 70 points ahead of Nifty futures’ last close.

On Monday, Indian equity benchmark indices BSE Sensex and Nifty 50 climbed to record highs, before finishing the trading session at all-time high levels. 




The BSE Sensex gained 384 points, or 0.45 per cent, to close at 84,928.61, after touching a record high of 84,980 during the day.




The Nifty 50 also touched an all-time high of 25,956, before closing 148 points higher or 0.57 per cent ahead at 25,939.

Asian stocks were perched at their highest levels in more than two months on Tuesday as expectations for more US rate cuts kept risk sentiment aloft, while investors awaited a policy decision from Australia’s central bank.




In an eagerly awaited press conference, China’s top financial regulators including the central bank unveiled a slew of measures to aid the stuttering economy, including moves to reduce mortgage rates for existing homes.




The Reserve Bank of Australia is widely expected to stand pat on rates but the Federal Reserve’s 50 basis point cut last week has raised some expectations Australia could follow the Fed.




MSCI’s broadest index of Asia-Pacific shares outside Japan rose 0.04 per cent to 586.31, while Japan’s Nikkei was the biggest mover in early trading, soaring 1.69 per cent to a near three-week high ahead of an eagerly awaited speech by Bank of Japan Governor Kazuo Ueda.




China’s central bank on Monday lowered its 14-day repo rate by 10 basis points, days after disappointing markets by not cutting longer-term rates.




Overnight, the US stocks closed modestly higher as traders digested the Fed’s big move last week, with policymakers explaining the need for the 50 bp cut.




Markets are currently evenly split on whether the US central bank will go for another 50 bps cut or a 25 bps cut in November, CME Fedwatch tool showed. They are pricing in 76 bps of easing this year.




Brown Brothers Harriman Senior Markets Strategist Elias Haddad said the market is overestimating the Fed’s capacity to ease. “However, it will likely take strong US jobs data to trigger a material upward reassessment in Fed funds rate expectations.”




The next non-farm payrolls report is due October 4 and until then, Haddad said a more dovish Fed and a strong US economy offer financial market risk sentiment support and can further undermine the dollar mostly against growth-sensitive currencies.




The dollar index, which measures the US currency against six rivals, was at 100.95, not far from the one-year low of 100.21 touched last week. The yen was little changed at 143.65 per dollar. 


In commodities, oil prices were slightly higher in early trading, with Brent crude futures up 0.26 per cent at $74.09 a barrel, while US crude futures were up 0.3 per cent at $70.6. Oil prices had slid on Monday on demand worries as well as weak economic data from Europe.

(With inputs from Reuters.)



Source link

YouTube
Instagram
WhatsApp